CNS Pharmaceuticals CNSP
NASDAQ CNSP
$5.24 -0.23 (-4.20%)
As of: Oct 1, 2026 · 1:41 PM EDT

CNS Pharmaceuticals (CNSP) Non Operating Interest Expenses (2018 - 2025)

Updated

CNS Pharmaceuticals (CNSP) reported Non Operating Interest Expenses of $2,721 for Q4 2025, down 1.9% from $2,774 a year earlier but up 28.6% from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Non Operating Interest Expenses (2018 - 2025) Analysis & Trends

For FY2025, CNS Pharmaceuticals posted Non Operating Interest Expenses of $15,230, down 5.5% from FY2024.

  • Non Operating Interest Expenses has a five-year compound annual growth rate of 36.1% (FY2020 to FY2025).
  • By year, Non Operating Interest Expenses came in at $16,120 in FY2024 (+16.8%), $13,805 in FY2023 (+96.5%), $7,027 in FY2022 (-24.3%) and $9,285 in FY2021 (+184.5%).
  • Five-year quarterly Non Operating Interest Expenses spans a low of $538.00 in Q3 2022 and a high of $6,625 in Q1 2024.
  • Year over year, Non Operating Interest Expenses has now declined in each of the last five quarters, with growth averaging 5.3% over the last eight quarters.
  • The high point for year-over-year Non Operating Interest Expenses in five years was Q3 2023 (growth of 241.6%); the low point was Q3 2022 (a decline of 43.2%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $2,116 (Q3 2025), $4,185 (Q2 2025) and $6,208 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 CNS Pharmaceuticals 2.35 Mn -39.89 Mn - 2,721.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2,721.00
Sep 30, 2025 2,116.00
Jun 30, 2025 4,185.00
Mar 31, 2025 6,208.00
Dec 31, 2024 2,774.00
Sep 30, 2024 2,258.00
Jun 30, 2024 4,463.00
Mar 31, 2024 6,625.00
Dec 31, 2023 2,881.00
Sep 30, 2023 1,838.00
Jun 30, 2023 3,650.00
Mar 31, 2023 5,436.00
Dec 31, 2022 2,312.00
Sep 30, 2022 538.00
Jun 30, 2022 1,611.00
Mar 31, 2022 2,566.00
Dec 31, 2021 2,238.00
Sep 30, 2021 947.00
Jun 30, 2021 2,353.00
Mar 31, 2021 3,747.00
API Access

CNS Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CNSP&period=max&api_key=YOUR_API_KEY